Sun Pharma Q3 PAT seen up 44.4% YoY to Rs 1,319 cr: ICICI Direct

ICICI Direct has come out with its third quarter (October-December’ 20) earnings estimates for the Healthcare sector. The brokerage house expects Sun Pharma to report net profit at Rs. 1,319  crore up 44.4% year-on-year (down 27.2% quarter-on-quarter).

Net Sales are expected to increase by 5.9 percent Y-o-Y (up 1 percent Q-o-Q) to Rs. 8,636 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 7.9 percent Y-o-Y (down 9.4 percent Q-o-Q) to Rs. 1,986.3 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.